BioHarvest Sciences (BHST) Expected to Announce Earnings on Monday

BioHarvest Sciences (NASDAQ:BHSTGet Free Report) is projected to release its earnings data before the market opens on Monday, March 31st. Analysts expect BioHarvest Sciences to post earnings of ($0.12) per share and revenue of $7.24 million for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

BioHarvest Sciences Trading Up 1.6 %

Shares of BHST stock opened at $6.55 on Friday. BioHarvest Sciences has a 52 week low of $6.53 and a 52 week high of $7.38. The stock’s 50 day moving average is $5.65. The firm has a market cap of $107.58 million, a P/E ratio of -5.24 and a beta of 2.27.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Maxim Group assumed coverage on shares of BioHarvest Sciences in a research note on Wednesday, December 18th. They issued a “buy” rating and a $12.00 price target for the company. HC Wainwright initiated coverage on BioHarvest Sciences in a research report on Friday, December 6th. They issued a “buy” rating and a $14.00 target price for the company.

Check Out Our Latest Analysis on BHST

BioHarvest Sciences Company Profile

(Get Free Report)

BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.

Featured Stories

Receive News & Ratings for BioHarvest Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioHarvest Sciences and related companies with MarketBeat.com's FREE daily email newsletter.